Genprex Shares Plunge Amid Heavy Selling Pressure

Genprex shares continue their downward trajectory, marked by significant price declines and surging trading activity. Technical indicators point to sustained selling momentum, leaving investors to wonder when this bearish trend might find a floor.

The biotech company’s stock extended its losing streak yesterday, dropping another 2.5% amid heavy trading. This latest decline contributes to a substantial 18.20% loss recorded over just ten trading sessions, with seven of those days closing in negative territory.

Market volatility reached extreme levels during yesterday’s session, with prices swinging between $0.175 and $0.2096—representing an intraday fluctuation range of 19.77%. These wild price movements underscore significant investor uncertainty about the company’s near-term prospects.

Volume Surge Confirms Bearish Sentiment

Trading volume tells a... Read more...